The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: A simulation study

BMC Medical Research Methodology

Volumn 14, Issue 1, 2014, Pages

  Pratt, Nicole L ^a   Ilomäki, Jenni ^a   Raymond, Chris ^b   Roughead, Elizabeth E ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b Canberra ACT   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; COMPUTER SIMULATION; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; HUMAN; INSURANCE; METHODOLOGY; TRENDS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; COMPUTER SIMULATION; DRUG UTILIZATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; INSURANCE; RESEARCH DESIGN;

EID: 84901693274     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-14-66     Document Type: Article

References (10)

1. The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Wahab IA, Pratt NL, Wiese MD, Kalisch LM, Roughead EE, Pharmacoepidemiol Drug Saf 2013 22 496 502 10.1002/pds.3417 23412832
2. Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis. Hallas J, Epidemiology 1996 7 478 484 10.1097/00001648-199609000-00004 8862977 (Pubitemid 26277691)
3. Misdiagnosis and mistreatment of a common side-effect-angiotensin- converting enzyme inhibitor-induced cough. Vegter S, Berg LT DJ-vd, Br J Clin Pharmacol 2010 69 200 203 10.1111/j.1365-2125.2009.03571.x 20233184
4. The effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis. Vegter S, De Boer P, Van Dijk KW, Visser S, Berg LT DJ-vd, Drug Saf 2013 36 435 439 10.1007/s40264-013-0024-z 23494997
5. Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis. Van Boven JF, Berg LT DJ-vd, Vegter S, Drug Saf 2013 36 231 236 10.1007/s40264-013-0029-7 23516006
6. Stroke risk and NSAIDs: an Australian population-based study. Caughey GE, Roughead EE, Pratt N, Killer G, Gilbert AL, Med J Aust 2011 195 525 529 10.5694/mja11.10055 22060087
7. Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis. Hersom K, Neary MP, Levaux HP, Klaskala W, Strauss JS, J Am Acad Dermatol 2003 49 424 432 10.1067/S0190-9622(03)02087-5 12963905 (Pubitemid 37051904)
8. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Tsiropoulos I, Andersen M, Hallas J, Pharmacoepidemiol Drug Saf 2009 18 483 491 10.1002/pds.1736 19326363
9. Modelling the market uptake of new drugs following listing for subsidy in Australia. A report from the Drug Utilisation Subcommittee of the Australian Pharmaceutical Benefits Advisory Committee. Birkett DJ, McManus P, Br J Clin Pharmacol 1995 40 407 410 10.1111/j.1365-2125.1995.tb04565.x 8554945
10. Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study. Pratt N, Andersen M, Bergman U, Choi NK, Gerhard T, Huang C, Kimura M, Kimura T, Kubota K, Lai CC, Ooba N, Osby U, Park BJ, Sato T, Shin JY, Sundström A, Yang YHK, Roughead EE, Pharmacoepidemiol Drug Saf 2013 22 915 924 23696036